ATE405557T1 - Substituierte imidazole als duale histamin h1 und h3 agonisten oder antagonisten - Google Patents

Substituierte imidazole als duale histamin h1 und h3 agonisten oder antagonisten

Info

Publication number
ATE405557T1
ATE405557T1 AT01971115T AT01971115T ATE405557T1 AT E405557 T1 ATE405557 T1 AT E405557T1 AT 01971115 T AT01971115 T AT 01971115T AT 01971115 T AT01971115 T AT 01971115T AT E405557 T1 ATE405557 T1 AT E405557T1
Authority
AT
Austria
Prior art keywords
agonists
antagonists
substituted imidazoles
dual histamine
histamine
Prior art date
Application number
AT01971115T
Other languages
English (en)
Inventor
Neng-Yang Shih
Robert Aslanian
John Piwinski
Andrew Lupo
Adriano Afonso
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE405557T1 publication Critical patent/ATE405557T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01971115T 2000-09-20 2001-09-18 Substituierte imidazole als duale histamin h1 und h3 agonisten oder antagonisten ATE405557T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23403800P 2000-09-20 2000-09-20

Publications (1)

Publication Number Publication Date
ATE405557T1 true ATE405557T1 (de) 2008-09-15

Family

ID=22879621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01971115T ATE405557T1 (de) 2000-09-20 2001-09-18 Substituierte imidazole als duale histamin h1 und h3 agonisten oder antagonisten

Country Status (14)

Country Link
US (1) US6528522B2 (de)
EP (1) EP1318993B1 (de)
JP (1) JP2004509869A (de)
CN (1) CN1558907A (de)
AR (1) AR031612A1 (de)
AT (1) ATE405557T1 (de)
AU (1) AU2001291040A1 (de)
CA (1) CA2422210C (de)
DE (1) DE60135471D1 (de)
ES (1) ES2311544T3 (de)
HK (1) HK1052180A1 (de)
MX (1) MXPA03002445A (de)
MY (1) MY120281A (de)
WO (1) WO2002024657A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
WO2014130534A1 (en) * 2013-02-19 2014-08-28 Icahn School Of Medicine At Mount Sinai Tricyclic heterocycles as anticancer agents
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
JP6966425B2 (ja) 2015-09-09 2021-11-17 アイカーン スクール オブ メディスン アット マウント サイナイIcahn School of Medicine at Mt. Sinai 抗がん剤としての複素環式の限定された三環系スルホンアミド
JP6955485B2 (ja) 2015-09-09 2021-10-27 アイカーン スクール オブ メディスン アット マウント サイナイＩｃａｈｎ Ｓｃｈｏｏｌ ｏｆ Ｍｅｄｉｃｉｎｅ ａｔ Ｍｔ． Ｓｉｎａｉ 抗がん剤としての複素環式の限定された三環系スルホンアミド

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586562B1 (fr) 1985-09-02 1989-03-10 Inst Nat Sante Rech Med Composition pharmaceutique contenant de l'a-methylhistamine
GB8916947D0 (en) 1989-07-25 1989-09-13 Smith Kline French Lab Medicaments
ATE109979T1 (de) 1990-03-30 1994-09-15 Heumann Pharma Gmbh & Co Verwendung von guanidinderivaten zur herstellung eines arzneimittels mit npy-antagonistischer wirkung.
GB9115740D0 (en) 1991-07-20 1991-09-04 Smithkline Beecham Plc Medicaments
WO1993012093A1 (en) 1991-12-18 1993-06-24 Schering Corporation Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists
US5352707A (en) 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
ATE234290T1 (de) 1993-11-15 2003-03-15 Schering Corp Phenylalkyl-imidazole als h3-rezeptor- antagonisten
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
ATE214604T1 (de) 1997-06-24 2002-04-15 Novo Nordisk As Verwendung von somatostatin agonisten und antagonisten zur behandlung von augenkrankheiten
US5869479A (en) 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses

Also Published As

Publication number Publication date
DE60135471D1 (de) 2008-10-02
US20020082272A1 (en) 2002-06-27
AU2001291040A1 (en) 2002-04-02
JP2004509869A (ja) 2004-04-02
MY120281A (en) 2005-09-30
CA2422210A1 (en) 2002-03-28
CN1558907A (zh) 2004-12-29
HK1052180A1 (zh) 2003-09-05
WO2002024657A2 (en) 2002-03-28
WO2002024657A3 (en) 2002-07-11
EP1318993B1 (de) 2008-08-20
AR031612A1 (es) 2003-09-24
US6528522B2 (en) 2003-03-04
EP1318993A2 (de) 2003-06-18
ES2311544T3 (es) 2009-02-16
CA2422210C (en) 2009-10-27
MXPA03002445A (es) 2003-06-19

Similar Documents

Publication Publication Date Title
ATE384053T1 (de) Triazolderivate als tachykininrezeptor- antagonisten
ATE461191T1 (de) N-substituierte 2-oxodihydropyridinderivate als npy antagonisten
DE60320529D1 (de) Chinolinderivate als npy antagonisten
IL164584A0 (en) (1-4-Piperidinyl) benzimidazole derivatives usefulas histamine H3 antagonists
DE60218340D1 (de) 5,6-diaryl-pyrazineamidderivate als cb1 antagonisten
ATE244236T1 (de) Substituierte azole
IS7782A (is) Setin píperasín, (1,4) díassepín og 2,5-díasabísýkló (2.2.1) heptön sem histamín H1 og/eða H3 mótlyf eða histamín H3 gagnmótlyf
ATE415391T1 (de) 1h-imidazol-derivate mit cb1-agonistischer, antagonistischer oder partialer agonistischer aktivität
ATE458479T1 (de) 1h-1,2,4- triazol-3- carboxamid derivate als cannabinoid-cb1 receptor liganden
ATE374191T1 (de) Urea derivate als integrin alpha 4 antagonisten
DE60316411D1 (de) Thiazolderivate als npy-rezeptorantagonisten
ATE283853T1 (de) Substituierte imidazole als duale histamine h1 und h3 agonisten oder antagonisten
ATE377008T1 (de) Imidazolderivate als glutamatrezeptorantagonisten
ATE245640T1 (de) Heterocyclische benzolsulfonamidderivate als bradykinin antagonisten
ATE387439T1 (de) Substituierte imidazole als duale histamin h1 und h3 agonisten oder antagonisten
DE60231897D1 (de) Triazol derivate als cyclooxygenase inhibitoren
ATE405557T1 (de) Substituierte imidazole als duale histamin h1 und h3 agonisten oder antagonisten
ATE411983T1 (de) Substituierte imidazole als histamine h1 und h3 agonisten oder antagonisten
ATE389658T1 (de) Heterocyclische kondensierte pyrazolderivate als kinaseinhibitoren
ATE264301T1 (de) Muscarin-antagonisten
ATE247121T1 (de) Imidazolderivate als phosphodiesterase vii-hemmer
ATE280161T1 (de) Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten
ATE495168T1 (de) Heteroarylsubstituierte imidazolderivate als glutamatrezeptorantagonisten
NO20033223D0 (no) Histamin-reseptor antagonister

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties